Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by deeppocket83on Jan 29, 2017 12:50pm
99 Views
Post# 25769630

RE:RE:RE:RE:RE:RE:RE:RE:Bill Ackman mystery position

RE:RE:RE:RE:RE:RE:RE:RE:Bill Ackman mystery positionYet they have 2 billion in free cash flow. hmmmm... They have more asset sales coming as well from products you didn't even know they had. Inova is the next to be sold close to a billion US. And maybe there is some thruth to that easter europe assets getting sold. Idiots thought there was going to be fire sales happening and yet they made fantastic money on the first batch of asset sales.
<< Previous
Bullboard Posts
Next >>